HKD 11.24
(1.81%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 381.01 Million CNY | 14.94% |
2022 | 331.49 Million CNY | -6.64% |
2021 | 355.06 Million CNY | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 500.92 Million CNY | 0.46% |
2024 Q1 | 498.64 Million CNY | 30.87% |
2023 Q4 | 381.01 Million CNY | 18.02% |
2023 FY | 381.01 Million CNY | 14.94% |
2023 Q3 | 322.83 Million CNY | 0.0% |
2023 Q1 | - CNY | -100.0% |
2022 Q4 | 331.49 Million CNY | 0.0% |
2022 FY | 331.49 Million CNY | -6.64% |
2021 FY | 355.06 Million CNY | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Uni-Bio Science Group Limited | 52.86 Million HKD | -620.701% |
CK Life Sciences Int'l., (Holdings) Inc. | 5.93 Billion HKD | 93.576% |